Bristol-Myers Squibb Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$807.43 | $636.99 | 8.68% | 9 | $727.01B |
| NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr928.80 | kr696.07 | 3.63% | 14 | kr4.12T |
| XOM | Exxon Mobil Corp | Outperform |
4
|
$113.42 | $124.27 | 19.03% | 3 | $447.22B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$146.97 | $174.55 | 15.67% | 3 | $353.71B |
| MRK | Merck | Outperform |
2
|
$129.49 | $130.51 | 11.21% | 11 | $327.97B |
| 857 | PetroChina Company | Outperform |
3
|
HK$7.67 | HK$6.10 | -4.69% | 2 | HK$1.90T |
| AZN | AstraZeneca PLC | Outperform |
17
|
£122.96 | £165.99 | 37.18% | 16 | £190.62B |
| NOVN | Novartis | Hold |
10
|
CHF91.74 | CHF105.00 | 17.31% | 9 | CHF187.19B |
| DHR | Danaher | Outperform |
10
|
$262.78 | $260.33 | 3.67% | 4 | $194.64B |
| AMGN | Amgen | Outperform |
4
|
$305.84 | $303.65 | 5.38% | 8 | $164.06B |
| PFE | Pfizer | Outperform |
2
|
$28.88 | $32.87 | 5.61% | 6 | $163.65B |
| MDT | Medtronic | Outperform |
11
|
$82.29 | $92.47 | 16.66% | 9 | $107.91B |
| 386 | China Petroleum & Chemical | Outperform |
3
|
HK$5.10 | HK$5.04 | -4.90% | 4 | HK$798.42B |
| BP. | BP p.l.c. | Outperform |
9
|
£4.83 | £7.50 | 55.28% | 13 | £79.07B |
| GSK | GSK | Outperform |
12
|
£17.75 | £17.30 | 12.39% | 12 | £72.36B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$228.79 | $284.47 | 22.38% | 8 | $66.12B |
| MRNA | Moderna | Outperform |
16
|
$166.61 | $135.42 | -24.37% | 1 | $63.85B |
| MMM | 3M | Hold |
10
|
$99.67 | $109.39 | 3.84% | 3 | $55.15B |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥4.75k | ¥4.92k | 28.48% | 0 | ¥7.81T |
| BAS | BASF | Outperform |
12
|
48.22€ | 49.50€ | 16.13% | 2 | 43.04€B |
| A | Agilent Technologies | Outperform |
10
|
$150.66 | $138.82 | 0.23% | 10 | $44.15B |
| CTVA | Corteva | Outperform |
12
|
$55.51 | $61.72 | 17.10% | 1 | $38.69B |
| BEI | Beiersdorf | Outperform |
17
|
146.20€ | 137.41€ | 1.92% | 3 | 32.72€B |
| BAYN | Bayer | Hold |
5
|
27.63€ | 45.15€ | 8.58% | 4 | 27.14€B |
| IOC | Indian Oil Corporation | Hold |
15
|
Rp168.80 | Rp136.48 | -8.47% | 8 | Rp2.32T |
| COLO B | Coloplast A/S | Hold |
18
|
kr844.20 | kr812.28 | 6.61% | 5 | kr189.81B |
| GMAB | Genmab A/S | Outperform |
16
|
kr1.93k | kr2.71k | 36.52% | 14 | kr124.37B |
| 4503 | Astellas Pharma | Outperform |
18
|
¥1.57k | ¥2.64k | 27.75% | 0 | ¥2.81T |
| BAX | Baxter International Inc | Hold |
17
|
$33.90 | $44.86 | 29.79% | 5 | $17.27B |
| ILMN | Illumina | Outperform |
16
|
$106.48 | $159.28 | 38.52% | 9 | $16.96B |
| BGNE | BeiGene | Buy |
6
|
$152.71 | $285.19 | 76.15% | 2 | $15.97B |
| 4523 | Eisai | Outperform |
18
|
¥6.76k | ¥9.58k | 24.19% | 0 | ¥1.97T |
| INCY | Incyte | Outperform |
9
|
$57.31 | $77.05 | 36.64% | 8 | $12.01B |
| AKZA | Akzo Nobel N.V. | Outperform |
18
|
64.48€ | 79.42€ | 21.74% | 16 | 10.93€B |
| 500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp5.86k | Rp5.67k | 3.16% | 25 | Rp977.65B |
| IPN | Ipsen | Outperform |
17
|
123.40€ | 127.95€ | -2.76% | 0 | 9.88€B |
| CRDA | Croda International Plc | Outperform |
18
|
£46.29 | £65.12 | 10.17% | 6 | £6.81B |
| 1801 | Innovent Biologics | Buy |
6
|
HK$35.90 | HK$50.72 | 42.06% | 6 | HK$60.20B |
| 5019 | Idemitsu Kosan | Outperform |
13
|
¥927.50 | ¥3.79k | -13.75% | 0 | ¥1.16T |
| 4528 | Ono Pharmaceutical | Hold |
18
|
¥2.25k | ¥2.76k | 9.08% | 0 | ¥1.09T |
| EXEL | Exelixis | Outperform |
16
|
$20.57 | $26.44 | 31.26% | 5 | $6.34B |
| 9926 | Akeso | Buy |
4
|
HK$37.05 | HK$49.90 | 48.80% | 0 | HK$43.73B |
| FPE3 | Fuchs | Outperform |
18
|
45.56€ | 43.45€ | 7.55% | 10 | 5.04€B |
| HLUN A | H. Lundbeck A/S | Outperform |
18
|
kr37.12 | kr190.00 | 5.06% | 6 | kr36.60B |
| APLS | Apellis Pharmaceuticals | Outperform |
6
|
$40.61 | $79.81 | 104.38% | 3 | $5.16B |
| CLN | Clariant | Outperform |
18
|
CHF15.01 | CHF16.11 | 6.60% | 6 | CHF4.67B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$27.88 | $44.75 | 43.47% | 0 | $4.19B |
| ALKS | Alkermes | Outperform |
10
|
$24.02 | $33.27 | 33.22% | 3 | $4.11B |
| 300003 | Lepu Medical Technology (Beiji... | Buy |
18
|
¥15.32 | ¥25.02 | 30.55% | 3 | ¥28.70B |
| IOVA | Iovance Biotherapeutics | Buy |
4
|
$10.01 | $20.42 | 149.75% | 4 | $3.76B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$10.44 | HK$3.96 | -63.22% | 0 | HK$26.30B |
| MOR | MorphoSys | Hold |
6
|
68.00€ | 28.78€ | 0.00% | 3 | 2.52€B |
| SDF | K+S | Hold |
8
|
13.50€ | 18.21€ | 17.78% | 8 | 2.51€B |
| BHC | Bausch Health Companies | Hold |
15
|
$6.36 | $9.50 | 49.37% | 5 | $2.55B |
| PFIZER | Pfizer | Outperform |
18
|
Rp4.50k | Rp4.53k | 9.58% | 3 | Rp204.63B |
| ARQT | Arcutis Biotherapeutics | Outperform |
4
|
$9.16 | $12.00 | 101.97% | 4 | $923.04M |
| 4569 | KYORIN Pharmaceutical | Underperform |
16
|
¥1.79k | ¥0.00 | -16.06% | 0 | ¥106.24B |
| 524735 | Hikal | Buy |
18
|
Rp294.45 | Rp328.00 | 12.07% | 1 | Rp36.36B |
| ORGO | Organogenesis Holdings | Outperform |
10
|
$2.63 | $4.75 | 90.11% | 1 | $401.69M |
| MXCT | MaxCyte | Buy |
8
|
£3.65 | £9.66 | 90.14% | 6 | £303.18M |
| AMRN | Amarin | Hold |
8
|
$0.85 | $2.05 | 17.65% | 1 | $378.19M |
| CDXS | Codexis | Buy |
6
|
$3.17 | $5.83 | 57.73% | 3 | $276.59M |
| CHRS | Coherus BioSciences | Outperform |
6
|
$1.91 | $10.86 | 318.85% | 3 | $255.37M |
| OMER | Omeros | Hold |
11
|
$3.35 | $13.00 | -100.00% | 2 | $241.63M |
| BLUE | bluebird bio | Hold |
6
|
$0.97 | $7.20 | 312.37% | 2 | $194.67M |
| IMP | Imexpharm | Outperform |
17
|
₫67.50k | ₫79.05k | 12.59% | 0 | ₫4.56T |
| DXB | Dimerix |
0
|
$0.34 | $0.00 | 70.59% | 0 | $186.89M | |
| KPTI | Karyopharm Therapeutics | Outperform |
6
|
$1.05 | $6.00 | 376.19% | 1 | $118.80M |
| IFRX | InflaRx N.V. | Outperform |
4
|
$1.44 | $9.44 | 416.67% | 2 | $85.38M |
| DMC | Domesco Medical Import - Expor... | - |
0
|
₫56.20k | ₫0.00 | -100.00% | 0 | ₫1.74T |
| BLRX | BioLineRx | - |
7
|
₪0.16 | ₪1.39 | -100.00% | 0 | ₪190.66M |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.17 | $0.65 | 488.24% | 0 | $44.04M |
| ONCO | Oncopeptides AB (publ) |
0
|
kr2.71 | kr6.90 | 136.16% | 0 | kr352.58M | |
| ACST | Acasti Pharma | Buy |
0
|
$2.72 | $16.34 | 196.32% | 0 | $26.98M |
| LSTA | Lisata Therapeutics | Buy |
8
|
$2.96 | $16.00 | 389.86% | 2 | $22.85M |
| TCRT | Alaunos Therapeutics | Hold |
7
|
$1.15 | $1.37 | -100.00% | 3 | $17.13M |
| MPH | Medicure | - |
0
|
C$1.29 | C$2.80 | -100.00% | 0 | C$15.13M |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp116.45 | Rp0.00 | -100.00% | 0 | Rp897.11M |
| GTG | Genetic Technologies | - |
0
|
$0.11 | $1.00 | -100.00% | 0 | $15.87M |
| AKTX | Akari Therapeutics, Plc | - |
2
|
$1.95 | $80.00 | -100.00% | 0 | $9.39M |
| BRTX | BioRestorative Therapies | Outperform |
0
|
$1.29 | $15.00 | 713.95% | 0 | $8.87M |
| EMMA | Emmaus Life Sciences | - |
0
|
$0.13 | $4.50 | -100.00% | 0 | $5.90M |
| APDN | Applied DNA Sciences | Outperform |
10
|
$1.99 | $2.50 | 1407.54% | 0 | $2.17M |
| IPCI | Intellipharmaceutics Internati... | - |
0
|
C$0.08 | C$30.00 | -100.00% | 0 | C$2.65M |
| ATHX | Athersys | - |
6
|
$0.00 | $5.50 | 0.00% | 1 | $0.87M |
| GSAC | GelStat | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.63M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.70 | $200.00 | -100.00% | 1 | $0.53M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |